Methylin en es it fr

Methylin Brand names, Methylin Analogs

Methylin Brand Names Mixture

  • No information avaliable

Methylin Chemical_Formula


Methylin RX_link

Methylin fda sheet

Methylin FDA

Methylin msds (material safety sheet)

Methylin MSDS

Methylin Synthesis Reference

M. Hartmann, L. Panizzon, U.S. Pat. 2,507,631 (1950)

Methylin Molecular Weight

233.306 g/mol

Methylin Melting Point


Methylin H2O Solubility


Methylin State


Methylin LogP


Methylin Dosage Forms

Tablets; Tablets (sustained release)

Methylin Indication

For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.

Methylin Pharmacology

Methylphenidate is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine.

Methylin Absorption

Readily absorbed in a biphasic manner. It reaches peak absorption at approximately two hours for the first phase and five hours for the second phase. Bioavailability is low (approximately 30%)

Methylin side effects and Toxicity

Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes. LD50=190mg/kg (orally in mice)

Methylin Patient Information

Methylin Organisms Affected

Humans and other mammals